A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
Polygenic risk scores, which estimate a person’s disease risk based on thousands or millions of common genetic variants, perform poorly in screening and prediction of common diseases such as heart disease.
A new international study from UCL and UCLH that aims to improve the quality of MRI scans for prostate cancer screening has identified simple ways to treble the number of scans that are of optimal diagnostic quality.
The time of day a patient takes medication for their high blood pressure makes no difference to how well the medication works, according to a large observational study.
Nearly 200 people have visited a family-friendly open event in Islington which engaged the local community in the latest research and innovation in the NHS.
UCL and Moorfields Eye Hospital have developed an AI system that has the potential not only to identify eye diseases but also to predict or identify other conditions.
The first UK participant in a portion of a study looking at a new investigational medication for Covid-19 has received their initial dose of the drug at UCLH.
A new UCLH study is hoping to reduce the time taken to diagnose lung cancer by using artificial intelligence (AI) software to detect abnormalities on chest X-rays.
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
The comprehensive review, co-authored by BRC Director Prof Bryan Williams, recommends approaches including mindfulness practices and reducing exposure to air polluion.
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Find out more.
